Cargando…
Regulation of Cdc42 signaling by the dopamine D2 receptor in a mouse model of Parkinson’s disease
Substantial spine loss in striatal medium spiny neurons (MSNs) and abnormal behaviors are common features of Parkinson's disease (PD). The caudate putamen (CPu) mainly contains MSNs expressing dopamine D1 receptor (dMSNs) and dopamine D2 receptor (iMSNs) exerting critical effects on motor and c...
Autores principales: | Ying, Li, Zhao, Jinlan, Ye, Yingshan, Liu, Yutong, Xiao, Bin, Xue, Tao, Zhu, Hangfei, Wu, Yue, He, Jing, Qin, Sifei, Jiang, Yong, Guo, Fukun, Zhang, Lin, Liu, Nuyun, Zhang, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124300/ https://www.ncbi.nlm.nih.gov/pubmed/35415964 http://dx.doi.org/10.1111/acel.13588 |
Ejemplares similares
-
Cdc42 Deficiency Leads To Epidermal Barrier Dysfunction by Regulating Intercellular Junctions and Keratinization of Epidermal Cells during Mouse Skin Development
por: Zhang, Min, et al.
Publicado: (2019) -
RhoA and Cdc42 in T cells: Are they targetable for T cell-mediated inflammatory diseases?
por: Guo, Fukun
Publicado: (2021) -
Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma
por: Nguyen, Phuong, et al.
Publicado: (2019) -
Distinct Roles of Cdc42 in Thymopoiesis and Effector and Memory T Cell Differentiation
por: Guo, Fukun, et al.
Publicado: (2011) -
The Borg family of Cdc42 effector proteins Cdc42EP1–5
por: Farrugia, Aaron J., et al.
Publicado: (2016)